Flu, chills and other ills: a wintry round-up of Cochrane evidence

This week it really feels like winter is upon us and infection is the dominant theme in this blog, which gives you a round-up of some new and updated Cochrane reviews on flu vaccination; antibiotics for colds, sore throats and for those having feeding tubes put in;  bringing down your poorly child’s temperature and whether avoiding lactose is helpful when diarrhoea strikes. Continue reading

Advertisements

Waiting for the royal baby? We’ve new arrivals in the Cochrane Library

July is proving to be an exciting month here in the UK. Andy Murray is the new Wimbledon Champion, we’re enjoying lots of wonderful warm weather and we’re anticipating the arrival of the new royal baby. But before the Duke and Duchess of Cambridge have news for us, we have news for them, for these are exciting times too in the world of Cochrane and yesterday saw the publication of new evidence that delaying clamping the cord after birth benefits babies. Continue reading

Preventing shingles in older adults: how effective and safe is vaccination? A new Cochrane review

  Key Message:Herpes zoster vaccine is effective in preventing shingles, with people aged 60 to 69 years benefitting more than older people but also experiencing more side effects. In general, the vaccine is well tolerated and most side effects are mild to moderate reactions at the injection site.  

Herpes zoster or ‘shingles’ is a painful condition, arising from the reactivation of varicella zoster virus, the virus that causes chicken pox. Older adults are particularly susceptible to shingles, which can last for weeks or months and have a significant impact on quality of life. A new review from the Cochrane Acute Respiratory Infections Group evaluated the effectiveness and safety of vaccination to prevent herpes zoster in adults aged sixty and over. The review includes eight randomized controlled trials with more than 52,000 participants but the main outcomes on effectiveness and safety come from the Shingles Prevention Study, a large trial with 38,546 participants, who were followed up for over three years. Continue reading